In 2018, our research team initially documented the occurrence of NETs formation in NASH, noting elevated levels of myeloperoxidase (MPO)-associated DNA (MPO-DNA), a hallmark of NETs, in the serum of preoperative NASH patients. The gene discussed is MPO; the disease is metabolic dysfunction-associated steatohepatitis.